Funding opportunities

This is a funding notice board for those looking for assistance in their diagnostics development. This will initially host many UK based funders that fund UK and international teams, but we will be researching and adding more funders based in other countries as well. To add an opportunity, longitude [dot] prize [at] nesta [dot] org [dot] uk (please email us).
To see more funding resources, such as general databases and websites, visit our Resources page

AMR Education Challenge Contest: Innovative Ways to Reduce Antimicrobial Resistance

The International Diagnostics Centre at the London School of Hygiene and Tropical Medicine is organising an open challenge crowd-sourcing contest to create open-access AMR resources. In this contest, they are asking participants to submit multiple-choice questions (MCQs), infographics, and/or images related to AMR. The focus should be on antimicrobial resistance, but they are particularly...
Deadline 15 June 2019

CARB-X Funding Round 3: Diagnostics

CARB-X Funding Round 3 for Diagnostics will be open for Expressions of Interest (EOI) August 12 – August 19, 2019, 5 PM ET. Expressions of Interest (EOI) accepted online only: The scope of Round 3 is restricted to diagnostics that will rapidly identify either the bacterial species or antibiotic susceptibility, or both. Only pathogen ID/AST approaches are in scope, as...
Deadline 12 August 2019

British Society for Antimicrobial Chemotherapy - Research Grants

BSAC supports research projects of relevance to antimicrobial chemotherapy. Priority is given to projects focusing on diagnostics, antimicrobial stewardship, virology, antibiotic adjuvants and molecular mechanisms of antimicrobial resistance.
diagnostics, biomarker, Antimicrobial Stewardship
Duration 12 Months
Deadline 29 November 2018 (Forecast)

PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA), issued by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA), invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications. United States SBCs that have the research capabilities and...
Small Business
Duration Award periods normally may not exceed 6 months for Phase I and 2 years for Phase II. Applicants are encouraged to propose a project duration period that is reasonable and appropriate for completion of the research projects.
Deadline Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Please see the website for additional details.